The NGFI-B subfamily of the nuclear receptor superfamily

International Journal of Oncology

Volumn 12, Issue 6, 1998, Pages 1237-1243

  Maruyama, Kouji ^a   Tsukada, Toshihiko ^a   Ohkura, Naganari ^a   Bandoh, Shuji ^a   Hosono, Tetsuji ^a   Yamaguchi, Ken ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Myxoid chondrosarcoma; NGFI B; Nuclear receptor superfamily; Retinoic acid signaling pathway

Indexed keywords

CELL NUCLEUS RECEPTOR; NERVE GROWTH FACTOR RECEPTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CHONDROSARCOMA; HORMONE RESPONSIVE ELEMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR INTRINSIC ACTIVITY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; TRANSCRIPTION FACTORS;

EID: 0031866761     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240: 889-895, 1988.
2. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG and Evans RM: Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635-641, 1985.
3. Miesfeld R, Rusconi S, Godowski PJ, Maler BA, Okret S, Wikström A-C, Gustafsson J-Å and Yamamoto KR: Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 46: 389-399, 1986.
4. Green S, Walter P, Kumar V, Krust A, Bornet J-M, Argos P and Chambon P: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320: 134-139, 1986.
5. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans RM: The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
6. Milbrandt J: Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183-188, 1988.
7. Law SW, Conneely OM, De Mayo FJ, O'Malley BW: Identification of a new brain-specific transcription factor, NURR1. Mol Endocrinol 6: 2129-2135, 1992.
8. Ohkura N, Hijikuro M, Yamamoto A and Miki K: Molecular cloning of a novel thyroid/steroid receptor superfamily gene from cultured rat neuronal cells. Biochem Biophys Res Commun 205: 1959-1965, 1994.
9. Berg JM: DNA binding specificity of steroid receptors. Cell 57: 1065-1068, 1989.
10. Klug A and Schwabe JWR: Zinc fingers. FASEB J 9: 597-604, 1995.
11. Forman BM and Samuels HH: Interactions among a subfamily of nuclear receptors: the regulatory zipper model. Mol Endocrinol 4: 1293-1301, 1990.
12. Davis IJ, Hazel TG, Chen R-H, Blenis J and Lau LF: Functional domains and phosphorylation of the orphan receptor Nur77. Mol Endocrinol 7: 953-964, 1993.
13. Wilson TE, Paulsen RE, Padgett KA and Milbrandt J: Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. Science 256: 107-110, 1992.
14. Chang C, Saltzman A, Lee H-J, Uemura H, Su C, Chodak G, Nakamoto T, Le Beau MM, Espinosa R, Davis E, Lemons RS, Sivak L and Shin C: Genomic structure, chromosomal localization and expression of an androgen inducible TR3 orphan receptor: a member of the steroid receptor superfamily. Endocr J 1: 541-549, 1993.
15. Mages HW, Rilke O, Bravo R, Senger G and Kroczek RA: NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3. Mol Endocrinol 8: 1583-1591, 1994.
16. Ohkura N, Ito M, Tsukada T, Sasaki K, Yamaguchi K and Miki K: Structure, mapping and expression of a human NOR-1 gene, the third member of the Nur77/NGFI-B family. Biochim Biophys Acta 1308: 205-214, 1996.
17. Watson MA and Milbrandt J: The NGFI-B gene, a transcriptionally inducible member of the steroid receptor gene superfamily: gcnomic structure and expression in rat brain after seizure induction. Mol Cell Biol 9: 4213-4219, 1989.
18. Saucedo-Cardenas O, Kardon R, Ediger TR, Lydon JP and Conneely OM: Cloning and structural organization of the gene encoding the murine nuclear receptor transcription factor, NURR1. Gene 187: 135-139, 1997.
19. Petropoulos I, Part D, Ochoa A, Zakin MM and Lamas E: NOR-2 (neuron-derived orphan receptor), a brain zinc finger protein, is highly induced during liver regeneration. FEBS Lett 372: 273-278, 1995.
20. Labelle Y, Zucman J, Stenman G, Kindblom L-G, Knight J, Turc-Carel C, Dockhom-Dworniczak B, Mandahl N, Desmaze C, Peter M, Aurias A, Delattre O and Thomas G: Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet 4: 2219-2226, 1995.
21. Shaw G and Kamen R: A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667, 1986.
22. Chang C, Kokontis J, Liao S and Chang Y: Isolation and characterization of human TR3 receptor: a member of steroid receptor superfamily. J Steroid Biochem 34: 391-395, 1989.
23. Nakai A, Kartha S, Sakurai A, Toback FG and De Groot LJ: A human early response gene homologous to murine nur77 and rat NGFI-B, and related to the nuclear receptor superfamily. Mol Endocrinol 4: 1438-1443, 1990.
24. Bondy GP: Phorbol ester, forskolin and serum induction of a human colon nuclear hormone receptor gene related to the NUR 77/NCFI-B genes. Cell Growth Differ 2: 203-208, 1991.
25. Hazel TG, Nathans D and Lau LF: A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci USA 85: 8444-8448, 1988.
26. Ryseck R-P, MacDonald-Bravo H, Mattél M-G, Ruppert S and Bravo R: Structure, mapping and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor. EMBO J 8: 3327-3335, 1989.
27. Varnum BC, Lim RW, Kujubu DA, Luner SJ, Kaufman SE, Greenberger JS, Gasson JC and Herschman HR: Glanulocytemacrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells. Mol Cell Biol 9: 3580-3583, 1989.
28. Okabe T, Takayanagi R, Imasaki K, Haji M, Nawata H and Watanabe T: cDNA cloning of a NGFI-B/nur77-related transcription factor from an apoptotic human T cell line. J Immunol 154: 3871-3879, 1995.
29. Scearce LM, Laz TM, Hazel TG, Lau LF and Taub R: RNR-1, a nuclear receptor in the NGFI-B/Nur77 family that is rapidly induced in regenerating liver. J Biol Chem 268: 8855-8861, 1993.
30. Peña de Oritz S and Jameison GA Jr: HZF-3, an immediateearly orphan receptor homologous to NURRI/NOT: induction upon membrane depolarization and seizures. Brain Res Mol Brain Res 38: 1-13, 1996.
31. Hedvat CV and Irving SG: The isolation and characterization of MINOR, a novel mitogen-inducible nuclear orphan receptor. Mol Endocrinol 9: 1692-1700, 1995.
32. Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J and Cooper CS: Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene 12: 229-235, 1996.
33. Wilson TE, Fahrner TJ, Johnston M and Milbrandt J: Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science 252: 1296-1300, 1991.
34. Wilson TE, Fahrner TJ and Milbrandt J: The orphan receptors NGFI-B and steroidgenic factor 1 establish monomer binding as a third paradism of nuclear receptor-DNA interaction. Mol Cell Biol 13: 5794-5804, 1993.
35. Perlmann T and Jansson L: A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURRI. Genes Dev 9: 769-782, 1995.
36. Forman BM, Umesono K, Chen J and Evans RM: Unique response pathway are established by allosteric interactions among nuclear hormone receptors. Cell 81: 541-550, 1995.
37. Leblanc BP and Stunnenberg HG: 9-Cis retinoic acid signaling: changing partners causes some excitement. Genes Dev 9: 1811-1816, 1995.
38. Zetterström RH, Solomin L, Mitsiadis T, Olson L and Perlmann T: Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurrl and Norl. Mol Endocrinol 10: 1656-1666, 1996.
39. Philips A, Lesage S, Gingras R, Maira M-H, Gauthier Y, Hugo P and Drouin J: Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol 17: 5946-5951, 1997.
40. Hirata Y, Kiuchi K, Chen H-C, Milbrandt J and Guroff G: The phosphorylation and DNA binding of the DNA-binding domain of the nuclear receptor NGFI-B. J Biol Chem 268: 24808-24812, 1993.
41. Katagiri Y, Hirata Y, Milbrandt J and Guroff G: Differential regulation of the transcriptional activity of the orphan nuclear receptor NGFI-B by membrane depolarization and nerve growth factor. J Biol Chem 272: 31278-31284, 1997.
42. Li Y and Lau LF: Adrenocorticotropic hormone regulates the activities of the orphan nuclear receptor Nur77 through modulation of phsphorylation. Endocrinology 138: 4138-4146, 1997.
43. Maruyma K, Tsukada T, Bandoh S, Sasaki K, Ohkura N and Yamaguchi K: Expression of NOR-1 and its closely related members of the steroid/thyroid hormone receptor superfamily in human neuroblastoma cell lines. Cancer Lett 96: 117-122, 1995.
44. Bandoh S, Tsukada T, Maruyama K, Ohkura N and Yamaguchi K: Mechanical agitation induces gene expression of NOR-1 and its closely related orphan nuclear receptors in leukemic cell lines. Leukemia 11: 1453-1458, 1997.
45. Miyakoshi J, Tsukada T, Tachiri S, Bandoh S, Yamaguchi K and Takebe H: Enhanced NOR-1 gene expression by exposure of chinese hamster cells to high-density 50 Hz magnetic fields. Mol Cell Biochem (In press).
46. Watson MA and Milbrandt J: Expression of the nerve growth factor-regulated NGFI-A and NGFI-B genes in the developing rat. Development 110: 173-183, 1990.
47. Maruyama K, Tsukada T, Bandoh S, Sasaki K, Ohkura N and Yamaguchi K: Expression of the putative transcription factor NOR-1 in the nervous, the endocrine and the immune systems and the developing brain of the rat. Neurocndocrinology 65: 2-8, 1997.
48. Bandoh S, Tsukada T, Maruyama K, Ohkura N and Yamaguchi K: Differential expression of NGFI-B and RNR-1 genes in various tissues and developing brain of the rat: Comparative study by quantitative reverse transcription-polymerase chain reaction. J Neuroendocrinol 9: 3-8, 1997.
49. Sauccdo-Cardenas O and Conneely OM: Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system. J Mol Neurosci 7: 51-63, 1996.
50. Zetterström RH, Williams R, Perlmann T and Olson L: Cellular expression of the immediate early transcription factors Nurrl and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res Mol Brain Res 41: 111-120, 1996.
51. Xiao Q, Castillo SO and Nikodem VM: Distribution of messenger RNAs for the orphan receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization. Neuroscience 75: 221-230, 1996.
52. Buono P, de Conciliis L, Izzo P and Salvatore F: The transcription of the human fructose-bisphosphate aldorase C gene is activated by nerve-growth-factor-induced B factor in human neuroblastoma cells. Biochem J 323: 245-250, 1997.
53. Ohkura N, Hijikuro M and Miki K: Antisense oligonucleotide to NOR-1, a novel orphan nuclear receptor, induces migration and neurite extension of cultured forebrain cells. Brain Res Mol Brain Res 35: 309-313, 1996.
54. Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L and Perlmann T: Dopamine neuron agenesis in Nurrl-deficient mice. Science 276: 248-250, 1997.
55. Imaki T, Shibasaki T, Chikada N, Harada S, Naruse M and Demura H: Different expression of immediate-early genes in the rat paraventricular nucleus induced by stress: relation to corticotropin-releasing factor gene transcription. Endocr J 43: 629-638, 1996.
56. Da Costa APC, Kampa RJ, Windle RJ, Ingram CD and Lightman SL: Region-specific immediate-early gene expression following the administration of corticotropin-releasing hormone in virgin and lactating rats. Brain Res 770: 151-162, 1997.
57. Davis IJ and Lau LF: Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands. Mol Cell Biol 14: 3469-3483, 1994.
58. Crawford PA, Sadovsky Y, Woodson K, Lee SL and Milbrandt J: Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol Cell Biol 15: 4331-4336, 1995.
59. Smith MA, Kim S-Y, van Oers HJ and Levine S: Maternal deprivation and stress induce immediate early genes in the infant rat brain. Endocrinology 138: 4622-4628, 1997.
60. Wilson TE, Mouw AR, Weaver CA, Milbrandt J and Parker KL: The orphan nuclear receptor NGFI-B regulates expression of the gene encoding steroid 21-hydroxylase. Mol Cell Biol 13: 861-868, 1993.
61. Simpson ER and Waterman MR: Regulation of the synthesis of steroidgenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 50: 427-440, 1988.
62. Murphy EP and Conneely OM: Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol 11: 39-47, 1997.
63. Nosal GJV: Negative selection of lymphocytes. Cell 76: 229-239, 1994.
64. Robey E and Fowlkes BJ: Selective events in T cell development. Annu Rev Immunol 12: 675-705, 1994.
65. von Boehmer H: Positive selection of lymphocytes. Cell 76: 219-228, 1994.
66. Allen PM: Peptides in positive and negative selection: a delicate balance. Cell 76: 593-596, 1994.
67. Woronicz JD, Calnan B, Ngo V and Winoto A: Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367: 277-281, 1994.
68. Liu Z-G, Smith SW, McLaughlin KA, Schwartz LM and Osborne BA: Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367: 281-284, 1994.
69. Calnan BJ, Szychowski S, Chan FK-M, Cado D and Winoto A: A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 3: 273-282, 1995.
70. Zhou T, Cheng J, Yang P, Wang Z, Liu C, Su X, Bluethmann H and Mountz JD: Inhibition of Nur77/Nurrl leads to inefficient clonal deletion of self-reactive T cells. J Exp Med 183: 1879-1892, 1996.
71. Weih F, Ryseck R-P, Chen L and Bravo R: Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc Natl Acad Sci USA 93: 5533-5538, 1996.
72. Cheng LE-C, Chan FK-M, Cado D and Winoto A: Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBOJ 16: 1865-1875, 1997.
73. Saleh G, Evans HL, Ro JY and Ayala AG: Extraskeletal myxoid chondrosarcoma: a clinicopathological study often patients with long-term follow-up. Cancer 70: 2827-2830, 1992.
74. Hinlichs SH, Jaramillo MA, Gumerlock PH, Gardner MB, Lewis JP and Freeman AE: Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22. Cancer Genet Cytogenet 14: 219-226, 1985.
75. Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL and Ladanyi M: Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol 150: 1049-1058, 1997.
76. Wasylyk B, Hahn SL and Giovane A: The Ets family of transcription factors. Eur J Biochem 211: 7-18, 1993.
77. Olmo T, Rao VN and Reddy ESP: EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res 53: 5859-5863, 1993.
78. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G and Denny CT: Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLII for transformation. Proc Natl Acad Sci USA 90: 5752-5756, 1993.
79. Lotan R: Effect of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605: 33-91, 1981.
80. Lippman SM, Kessler JF and Meyskens FL Jr: Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71: 391-405 (Part I), 493-515 (Part II), 1987.
81. Lippman SM, Kessler JF and Meyskens FL Jr: Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71: 391-405 (Part I), 493-515 (Part II), 1987.
82. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhao L, Gu LJ and Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572, 1988.
83. Chomienne C, Ballerini P, Balitrand N, Amar M, Bernard JF, Boivin P, Daniel MT, Berger R, Castaigne S and Degos L: Retinoic acid therapy for promyelocytic leukaemia. Lancet 23: 746-747, 1989.
84. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P and Dcgos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76: 1704-1709, 1990.
85. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon M and Dmitrovsky E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385-1393, 1991.
86. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper P and Strong S: 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501-1505, 1986.
87. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW and Goepfert H: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323: 795-801, 1990.
88. Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU and Hong WK: 13-cis-retinoic acid and interferon α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84: 235-241, 1992.
89. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueno F, Paredes-Casillas P, Hong WK, Holdener E and Krakoff IH: 13-cis-retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84: 241-245, 1992.
90. Lacroix A and Lippman ME: Binding of retinoids to human breast cancer cell lines and their effects on cell growth. J Clin Invest 65: 586-591, 1980.
91. van der Burg B, van der Leede B-JM, Kwakkenbos-Isbrücker L, Salverda S, De Laat SW and van der Saag PT: Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91: 149-157, 1993.
92. Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J, Miller WH Jr: 9-cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res 54: 6549-6556, 1994.
93. Liu Y, Lee M-O, Wang H-G, Li Y, Hashimoto Y, Klaus M, Reed JC and Zhang X-K: Retinoic acid receptor ß mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16: 1138-1149, 1996.
94. Maruyama K, Tsukada T, Bandoh S, Sasaki K, Ohkura N and Yamaguchi K: Retinoic acids differentially regulate NOR-1 and its closely related orphan nuclear receptor genes in breast cancer cell line MCF-7. Biochem Biophys Res Commun 231: 417-420, 1997.
95. Warrell RP Jr, De Thé H, Wang Z-Y and Degos L: Acute promyelocytic leukemia. N Engl J Med 329: 177-189, 1993.
96. Hong WK and Itri LM: Retinoids and human cancer. In: The Retinoids. 2nd edition. Sporn MB, Roberts AB and Goodman DS (eds.) Raven Press, New York, pp597-630, 1994.
97. Zhang X-K, Liu Y, Lee M-O and Pfahl M: A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res 54: 5663-5669, 1994.
98. Wu Q, Li Y, Liu R, Agadir A, Lee M-O, Liu Y and Zhang X-K: Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J 16: 1656-1669, 1997.
99. Wu Q, Dawson MI, Zheng Y, Hobbs PD, Agadir A, Jong L, Li Y, Liu R, Lin B and Zhang X-K: Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol 17: 6598-6608, 1997.